Results 1 to 2 of 2

Thread: Endo International plc (NASDAQ:ENDP)

  1. #1
    Super Moderator
    Join Date
    Apr 2015
    Posts
    2,383

    Endo International plc (NASDAQ:ENDP)

    Endo International plc is global specialty healthcare company focused on improving patients' lives while creating shareholder value. It was created as a result of a management buyout from DuPont Merck in 1997. Three DuPont Merck executives (Carol A. Ammon, Chairman, President & CEO, and Mariann T. MacDonald, Executive Vice President, Operations, along with another colleague) purchased all of Endo Laboratories L.L.C.'s generic products along with 12 important brand products, including Percocet, Percodan, and Opana. The new company was called "Endo Pharmaceuticals Inc."

    Endo acquired Algos Pharmaceutical Corporation through a merger in July 2000 and began to trade publicly (NASDAQ: ENDP).

    Official website: www.endo.com

  2. #2
    Endo International (NASDAQ:ENDP) has crashed from a high of near $100 in 2015 to a low of $13.63 today. The stock is a pharma play that is tied into the same sector as $VRX. With tons of scrutiny, this sector has been crushed.

    Ultimately, everything bounces at some point and $ENDP is nearing major monthly support in a very oversold condition. Look for major support between $12-$13/share. Note the chart below...




    Gareth Soloway
    InTheMoneyStocks

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
About us
StockMarketsReview.com provides news coverage, analysis and researches for world stock markets, commodities and currencies. We publish articles provided by experts of leading brokerage and investment companies. At our website investors can find daily, weekly and monthly reports, news, recommendations on the IPOs and fundamental analysis for stocks which are currently traded at the stock exchange.